Rehak Laura, Giurato Laura, Meloni Marco, Panunzi Andrea, Manti Giada Maria, Uccioli Luigi
Athena Biomedical Innovations, Viale Europa 139, 50126 Florence, Italy.
Diabetic Foot Unit, Department Internal Medicine, Policlinico Tor Vergata Teaching Hospital, 00133 Rome, Italy.
J Clin Med. 2022 Feb 8;11(3):889. doi: 10.3390/jcm11030889.
Monocytes and lymphocytes play a key role in physiologic wound healing and might be involved in the impaired mechanisms observed in diabetes. Skin wound macrophages are represented by tissue resident macrophages and infiltrating peripheral blood recruited monocytes which play a leading role during the inflammatory phase of wound repair. The impaired transition of diabetic wound macrophages from pro-inflammatory M1 phenotypes to anti-inflammatory pro-regenerative M2 phenotypes might represent a key issue for impaired diabetic wound healing. This review will focus on the role of immune system cells in normal skin and diabetic wound repair. Furthermore, it will give an insight into therapy able to immuno-modulate wound healing processes toward to a regenerative anti-inflammatory fashion. Different approaches, such as cell therapy, exosome, and dermal substitute able to promote the M1 to M2 switch and able to positively influence healing processes in chronic wounds will be discussed.
单核细胞和淋巴细胞在生理性伤口愈合中起关键作用,可能参与了糖尿病中观察到的受损机制。皮肤伤口巨噬细胞由组织驻留巨噬细胞和浸润的外周血招募单核细胞组成,它们在伤口修复的炎症阶段起主导作用。糖尿病伤口巨噬细胞从促炎M1表型向抗炎促再生M2表型的受损转变可能是糖尿病伤口愈合受损的关键问题。本综述将聚焦于免疫系统细胞在正常皮肤和糖尿病伤口修复中的作用。此外,还将深入探讨能够以再生抗炎方式免疫调节伤口愈合过程的治疗方法。将讨论不同的方法,如细胞疗法、外泌体和皮肤替代物,它们能够促进M1向M2转换,并对慢性伤口的愈合过程产生积极影响。